| Financial Year |
March 31 2022 |
| Monetary Funds |
58,802,967.93 |
| Held-for-trading Financial Assets |
40,954.87 |
| Notes Receivable |
-- |
| Accounts Receivable |
115,915,591.13 |
| Advances to Suppliers |
100,247,051.88 |
| Other Receivables |
2,504,238,731.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
6,837,328.80 |
| Dividend Receivable |
-- |
| Inventories |
34,650,893.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,930,770.04 |
| Total Current Assets |
2,851,826,961.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
261,596,138.23 |
| Investment Properties |
-- |
| Fixed Assetes |
201,184,130.42 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,133,400.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,583,349.85 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
13,614,059.50 |
| Sub-Total of Non-Current Assets |
1,256,601,426.63 |
| Total Assets |
4,108,428,388.12 |
| Short-Term Loans |
2,652,427,848.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
259,832,415.44 |
| Accounts Received In Advance |
63,397,942.18 |
| Employee Compensation Payable |
28,308,654.47 |
| Taxes Payable |
36,186,332.03 |
| Interest Payable |
955,563,978.89 |
| Dividend Payable |
3,064,125.08 |
| Other payables |
1,243,464,085.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
297,612,121.21 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,581,229,398.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
993,266,474.81 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,026,174,705.84 |
| Total Liabilities |
5,607,404,104.65 |
| Paid-In Capital(Or Share Stock) |
614,975,393.00 |
| Capital Surplus |
1,091,135,034.26 |
| Surplus Reserve |
97,567,143.54 |
| LESS:Treasury Stock |
16,059,392.58 |
| Undistributed Profits |
-3,253,960,735.53 |
| Minority Stockholder's Interest |
-202,782,367.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,296,193,349.39 |
| Owner's Equity（Stockholder's Equity） |
-1,498,975,716.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,108,428,388.12 |
